Stryker Corporation $SYK Shares Sold by Middleton & Co. Inc. MA

Middleton & Co. Inc. MA lowered its stake in shares of Stryker Corporation (NYSE:SYK) by 6.6% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 22,995 shares of the medical technology company’s stock after selling 1,633 shares during the quarter. Middleton & Co. Inc. MA’s holdings in Stryker were worth $6,333,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of SYK. Gables Capital Management Inc. bought a new position in shares of Stryker during the second quarter worth $25,000. Kilter Group LLC purchased a new position in Stryker during the second quarter valued at $25,000. Cornerstone Financial Management LLC grew its stake in Stryker by 66.0% during the second quarter. Cornerstone Financial Management LLC now owns 78 shares of the medical technology company’s stock valued at $25,000 after acquiring an additional 31 shares in the last quarter. Highland Investment Advisors LLC bought a new stake in Stryker in the 2nd quarter valued at $25,000. Finally, Compass Financial Management LLC bought a new stake in Stryker in the 2nd quarter valued at $27,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Insiders Place Their Bets

In other news, Director Ronda Stryker sold 300,000 shares of the business’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $335.90, for a total value of $100,770,000.00. Following the sale, the director directly owned 2,301,375 shares in the company, valued at $773,031,862.50. The trade was a 11.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Dylan Crotty sold 441 shares of the company’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $328.61, for a total transaction of $144,917.01. Following the sale, the insider owned 6,102 shares in the company, valued at $2,005,178.22. This represents a 6.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 351,267 shares of company stock valued at $118,197,701 in the last three months. Corporate insiders own 4.60% of the company’s stock.

Stryker Trading Up 0.2%

SYK stock opened at $307.65 on Friday. The firm has a fifty day moving average price of $295.23 and a 200 day moving average price of $311.93. Stryker Corporation has a fifty-two week low of $267.00 and a fifty-two week high of $389.33. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16. The firm has a market cap of $118.01 billion, a PE ratio of 31.88, a price-to-earnings-growth ratio of 1.98 and a beta of 0.78.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share for the quarter, topping the consensus estimate of $3.49 by $0.20. The company had revenue of $6.59 billion for the quarter, compared to analysts’ expectations of $6.58 billion. Stryker had a net margin of 14.43% and a return on equity of 23.63%. Stryker’s quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $3.13 earnings per share. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Sell-side analysts anticipate that Stryker Corporation will post 14.93 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend is Wednesday, September 30th. Stryker’s dividend payout ratio (DPR) is presently 36.48%.

Wall Street Analyst Weigh In

Several analysts have commented on SYK shares. Wall Street Zen cut shares of Stryker from a “buy” rating to a “hold” rating in a research note on Saturday, October 3rd. Raymond James Financial set a $370.00 price objective on Stryker in a research report on Friday, July 31st. Argus set a $370.00 target price on Stryker in a report on Thursday, July 9th. Citigroup reduced their target price on Stryker from $399.00 to $360.00 and set a “buy” rating on the stock in a report on Thursday, September 10th. Finally, Royal Bank Of Canada decreased their target price on Stryker from $435.00 to $420.00 and set an “outperform” rating on the stock in a research report on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, Stryker presently has a consensus rating of “Moderate Buy” and an average target price of $369.00.

About Stryker

Stryker Corporation (NYSE: SYK) is a global medical technology company that develops and manufactures products used by healthcare providers in hospitals, surgical centers and other clinical settings. Its offerings are designed to support orthopaedic procedures, surgery, emergency care, neurovascular treatment and patient handling.

The company’s product portfolio includes orthopaedic implants and instruments, products for trauma and spine procedures, surgical equipment, endoscopy systems, patient beds and stretchers, emergency medical equipment, and neurovascular devices used in the treatment of conditions such as stroke.